Meet the executive leaders at Bristol Myers Squibb who are not only responsible for day-to-day operations, but are also innovators in the biotech industry committed to patients, customers, …

By pursuing meaningful work and valuing the people around him, says Chris Boerner, who was recently named board chair and CEO of Bristol Myers Squibb (BMS). Boerner swore off science after …

Mar 31, 2024 · Today Chris Boerner begins his new role as our CEO and on April 1, 2024, he’ll succeed Giovanni Caforio as Chair of the Board of Directors.

Bristol Myers Squibb's Chief Executive Officer and Director is Chris Boerner. Other executives include Sandra Leung, Executive Vice President, General Counsel; David Elkins, Executive Vice President …

Chris Boerner, PhD is the Board Chair and Chief Executive Officer of Bristol Myers Squibb. Learn more.

Oct 31, 2023 · Boerner was named Executive Vice President, Chief Operating Officer and CEO-elect on April 26 and, as of November 1, Boerner will be Chief Executive Officer of Bristol Myers Squibb. “ I...

Nov 1, 2023 · Boerner was named executive vice president, chief operating officer and CEO-elect on April 26 and, as of Nov. 1, Boerner will be CEO of Bristol Myers Squibb. “I am honored to become …

Bristol-Myers Squibb's CEO is Chris Boerner, appointed in Nov 2023, has a tenure of 2.17 years. total yearly compensation is $18.79M, comprised of 8.2% salary and 91.8% bonuses, including company …

Learn more about Chris Boerner, PhD, board chair and chief executive officer at Bristol Myers Squibb. Leading with innovation to deliver vital medicines worldwide.

Jan 12, 2026 · SAN FRANCISCO—Bristol Myers Squibb is already aiming to launch more than 10 new medicines by 2030. But to hear CEO Chris Boerner, Ph.D., tell it, “business development remains a …